We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
-4.62%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$74.4B
AUM Growth
+$4.15B
Cap. Flow
+$8.44B
Cap. Flow %
11.35%
Top 10 Hldgs %
19.16%
Holding
4,480
New
238
Increased
1,135
Reduced
2,408
Closed
335

Sector Composition

Rank Sector Weight
1 Technology 12.15%
2 Consumer Discretionary 6.92%
3 Financials 5.66%
4 Healthcare 5.15%
5 Industrials 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USMV icon
3576
iShares MSCI USA Min Vol Factor ETF
USMV
$24.6B
$14K ﹤0.01%
+180
New +$13.6K
INOD icon
3577
Innodata
INOD
$2.03B
$13.9K ﹤0.01%
1,987
-2,815
-59% -$16.5K
TCDA
3578
DELISTED
Tricida, Inc. Common Stock
TCDA
$13.9K ﹤0.01%
+1,688
New +$15.3K
REV
3579
DELISTED
Revlon, Inc.
REV
$13.5K ﹤0.01%
1,676
-1,837
-52% -$17.6K
DNTH icon
3580
Dianthus Therapeutics
DNTH
$6.13B
$13.5K ﹤0.01%
291
-124
-30% -$6.77K
SGU icon
3581
Star Group
SGU
$411M
$13.5K ﹤0.01%
1,217
-34
-3% -$356
REKR icon
3582
Rekor Systems
REKR
$97.6M
$13.5K ﹤0.01%
2,959
-4,506
-60% -$21.2K
NODK icon
3583
NI Holdings
NODK
$313M
$13.3K ﹤0.01%
782
-2,979
-79% -$53.4K
CXSE icon
3584
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
$494M
$12.7K ﹤0.01%
318
+218
+218% +$9.85K
TXMD icon
3585
TherapeuticsMD
TXMD
$24.1M
$12.7K ﹤0.01%
670
-935
-58% -$14.7K
EVI icon
3586
EVI Industries
EVI
$209M
$12.6K ﹤0.01%
677
-500
-42% -$10.9K
BSCM
3587
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
$12.3K ﹤0.01%
+580
New +$12.4K
BSJN
3588
DELISTED
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
$12.3K ﹤0.01%
503
+501
+25,050% +$12.4K
BSJP
3589
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
$12.3K ﹤0.01%
+517
New +$12.4K
TCRT icon
3590
Alaunos Therapeutics
TCRT
$4.86M
$12.1K ﹤0.01%
124
-160
-56% -$20.5K
IBIO icon
3591
iBio
IBIO
$69.5M
$12.1K ﹤0.01%
57
-115
-67% -$24.1K
IXJ icon
3592
iShares Global Healthcare ETF
IXJ
$4.23B
$12.1K ﹤0.01%
+138
New +$11.7K
ITI
3593
DELISTED
Iteris, Inc.
ITI
$12K ﹤0.01%
4,021
-5,426
-57% -$18.8K
CTSO icon
3594
Cytosorbents Corp
CTSO
$22.8M
$12K ﹤0.01%
3,751
-5,227
-58% -$18.7K
JHMM icon
3595
John Hancock Multifactor Mid Cap ETF
JHMM
$6.18B
$11.9K ﹤0.01%
+227
New +$11.8K
MIC
3596
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$11.9K ﹤0.01%
3,191
-187,880
-98% -$688K
VB icon
3597
Vanguard Morningstar Small-Cap ETF
VB
$83.4B
$11.9K ﹤0.01%
56
+38
+211% +$8K
CSSE
3598
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$11.9K ﹤0.01%
1,488
-38
-2% -$397
WF icon
3599
Woori Financial
WF
$17.2B
$11.8K ﹤0.01%
+312
New +$11.3K
HBB icon
3600
Hamilton Beach Brands
HBB
$447M
$11.6K ﹤0.01%
996
-1,557
-61% -$20.2K

Similar funds

BNP Paribas Financial Markets's Q1 2022 Portfolio in Review

As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.

  • BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
  • BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
  • BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
  • BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
  • BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
  • BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
  • BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.